PD-1ImmunotherapyCombinedwithGemcit-abineChemotherapyinMultilineTreatmentofAdvancedPancreaticCancer.[J].ComputMathMethodM,2022,2022:4070060.[13]YeY,ZhengS.SuccessfulImmunotherapyforPancreaticCancerinaPatientWithTSC2andSMAD4Mutations:ACaseReport[J].FrontImmunol,2021,12:785400.[14]XieC,DuffyAG,BrarG,etal.ImmuneCheck-pointBlockadeinCombinationwithStereotac-ticBodyRadiotherapyinPatientswithMeta-staticPancreaticDuctalAdenocarcinoma.[J].ClinCancerRes,2020,26(10):2318-2326.[15]MelisiD,OhDY,HollebecqueA,etal.SafetyandactivityoftheTGFβreceptorIkinasein-hibitorgalunisertibplustheanti-PD-L1anti-bodydurvalumabinmetastaticpancreaticcanc-er[J].JImmunotherCancer,2021,9(3):e002068.[16]RenoufDJ,LoreeJM,KnoxJJ,etal.TheCCTGPA.7phaseIItrialofgemcitabineandnab-paclitaxelwithorwithoutdurvalumabandtremelimumabasinitialtherapyinmeta-staticpancreaticductaladenocarcinoma[J].NatCommun,2022,13(1):5020.[17]WuAA,BeverKM,HoWJ,etal.APhaseIIStudyofAllogeneicGM-CSF-TransfectedPan-creaticTumorVaccine(GVAX)withIpili-mumabasMaintenanceTreatmentforMeta-staticPancreaticCancer[J].CLINCANCERRES,2020,26(19):5129-5139.[18]PothuriV,HerndonJ,BallentineSJ,etal.ACaseofaPathologicalCompleteResponsetoNeoadjuvantNivolumabplusIpilimumabinPeriampullaryAdenocarcinoma.[J].Oncolo-gist,2021,26(9):722-726.(收稿日期:2022-10-09修回日期:2023-05-04)△通信作者,E-mail:2456373169@qq.com。·综述·不同材料牙种植体特性及临床应用的研究进展韩帅1综述,李潇2,孙江伟1,尼加提·吐尔逊1△审校(1.新疆医科大学第二临床医学院(第二附属医院),新疆乌鲁木齐830063;2.新疆医科大学第五临床医学院(第五附属医院),新疆乌鲁木齐830011)[摘要]种植体材料应具有稳定的生物相容性及良好的力学性能,自1965年Branemark首次提出骨结合这一概念后,种植技术便开始了迅速的发展,而有关种植体材料方面的研究也是层出不穷,本文对近些年不同材料口腔种植体的特性及临床应用的研究现状及进展做一综述。[关键词]材料;种植体DOI:10.3969/j.issn.1009-5519.2023.25.008文章编号:1009-5519(2023)25-0021-03文献标识码:A口腔种植技术作为修复口内缺失患牙的治疗方法之一,与传统义齿修复相比,在治疗后的咀嚼功能、舒适...
